452 related articles for article (PubMed ID: 34268641)
1. The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies.
Chhichholiya Y; Suman P; Singh S; Munshi A
Med Oncol; 2021 Jul; 38(8):95. PubMed ID: 34268641
[TBL] [Abstract][Full Text] [Related]
2. Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood-brain barrier and treatment strategies.
Chhichholiya Y; Ruthuparna M; Velagaleti H; Munshi A
Clin Transl Oncol; 2023 May; 25(5):1218-1241. PubMed ID: 36897508
[TBL] [Abstract][Full Text] [Related]
3. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-based therapeutic targeting of signaling pathways in breast cancer.
Misra G; Qaisar S; Singh P
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166872. PubMed ID: 37666438
[TBL] [Abstract][Full Text] [Related]
5. New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer.
Ahmed M; Daoud GH; Mohamed A; Harati R
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34066014
[TBL] [Abstract][Full Text] [Related]
6. Genomic pathways modulated by Twist in breast cancer.
Vesuna F; Bergman Y; Raman V
BMC Cancer; 2017 Jan; 17(1):52. PubMed ID: 28086829
[TBL] [Abstract][Full Text] [Related]
7. Regulation of breast cancer metastasis signaling by miRNAs.
Petri BJ; Klinge CM
Cancer Metastasis Rev; 2020 Sep; 39(3):837-886. PubMed ID: 32577859
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the current knowledge limitations in breast cancer research: a gap analysis.
Thompson A; Brennan K; Cox A; Gee J; Harcourt D; Harris A; Harvie M; Holen I; Howell A; Nicholson R; Steel M; Streuli C
Breast Cancer Res; 2008; 10(2):R26. PubMed ID: 18371194
[TBL] [Abstract][Full Text] [Related]
9. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study.
Kutasovic JR; McCart Reed AE; Males R; Sim S; Saunus JM; Dalley A; McEvoy CR; Dedina L; Miller G; Peyton S; Reid L; Lal S; Niland C; Ferguson K; Fellowes AP; Al-Ejeh F; Lakhani SR; Cummings MC; Simpson PT
J Pathol Clin Res; 2019 Jan; 5(1):25-39. PubMed ID: 30246500
[TBL] [Abstract][Full Text] [Related]
12. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.
McAllister SD; Murase R; Christian RT; Lau D; Zielinski AJ; Allison J; Almanza C; Pakdel A; Lee J; Limbad C; Liu Y; Debs RJ; Moore DH; Desprez PY
Breast Cancer Res Treat; 2011 Aug; 129(1):37-47. PubMed ID: 20859676
[TBL] [Abstract][Full Text] [Related]
13. Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis.
Borin TF; Angara K; Rashid MH; Achyut BR; Arbab AS
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29292756
[TBL] [Abstract][Full Text] [Related]
14. Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer.
Yun J; Frankenberger CA; Kuo WL; Boelens MC; Eves EM; Cheng N; Liang H; Li WH; Ishwaran H; Minn AJ; Rosner MR
EMBO J; 2011 Aug; 30(21):4500-14. PubMed ID: 21873975
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-mediated targeting of HER2 inhibits cell proliferation through a dominant negative mutation.
Wang H; Sun W
Cancer Lett; 2017 Jan; 385():137-143. PubMed ID: 27815036
[TBL] [Abstract][Full Text] [Related]
16. The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancer.
Brockton NT; Gill SJ; Laborge SL; Paterson AH; Cook LS; Vogel HJ; Shemanko CS; Hanley DA; Magliocco AM; Friedenreich CM
BMC Cancer; 2015 Jul; 15():512. PubMed ID: 26156521
[TBL] [Abstract][Full Text] [Related]
17. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
[TBL] [Abstract][Full Text] [Related]
18. The Role of Breast Cancer Stem Cells and Some Related Molecular Biomarkers in Metastatic and Nonmetastatic Breast Cancer.
El Abbass KA; Abdellateif MS; Gawish AM; Zekri AN; Malash I; Bahnassy AA
Clin Breast Cancer; 2020 Aug; 20(4):e373-e384. PubMed ID: 32299754
[TBL] [Abstract][Full Text] [Related]
19. [Biology of cancer metastasis].
Robert J
Bull Cancer; 2013 Apr; 100(4):333-42. PubMed ID: 23587644
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide CRISPR/Cas9 knockout screening uncovers ZNF319 as a novel tumor suppressor critical for breast cancer metastasis.
Wang L; Zhou L; Li M; Zhao J; Liu Y; Chen Y; Qin X; Wang S; Chen H; Piao Y; Xiang R; Li J; Shi Y
Biochem Biophys Res Commun; 2022 Jan; 589():107-115. PubMed ID: 34902746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
